Mordor Intelligence is pleased to announce the publication of the report on Global Preventive Vaccines Market on November 24, 2015. This report discusses the Global Preventive Vaccines market in detail.
The report is a study on the Global Preventive Vaccines market along with an in-depth analysis of Asian, North-American, European and other regional markets.
Preventive Vaccines are administered to healthy individuals who are free from target infections. Here, a part of the virus or inactive virus or modified microbes is introduced in the body which leads to release of antibodies by the immune system. If after a period of time, these antibodies released will fight against the virus. Preventive vaccines have been classified based on its types like Live, Attenuated Vaccines, Inactivated vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugated Vaccines, DNA Vaccines, recombinant vector vaccines etc. Based on applications of the vaccines it have been subdivided into Pneumococcal, Varicella, MMR, Poliovirus, Hepatitis, HIB, Influenza, Cervical Cancer, Zoster and Others.
The global market for Preventive Vaccines grew rapidly from USD 5 billion in 2000 to USD 24 billion in 2013. With 120 new vaccines in the pipeline for various companies globally, which are set to hit the market in next 5 years, it is expected the global preventive vaccines market to grow by a healthy CAGR of 12.4% until 2020.
Globally, North America occupies the biggest market share but Asia will be having the largest market growth rate during the forecast period.
Get the full report here: Global Preventive Vaccines Market
The major players in the preventive vaccines market are Sanofi-Aventis, Merck, GlaxoSmithKline, Novartis, Pfizer, Serum Institute and others.
Subscribe to free alerts or browse our comprehensive literature on Healthcare: